PCM
DXCM icon

Peregrine Capital Management’s DexCom DXCM Stock Holding History

Peregrine Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.8M Buy
664,581
+48,041
+8% +$3.2M 1.45% 11
2026
Q1 		$38.7M Sell
616,540
-41,279
-6% -$2.87M 1.44% 14
2025
Q4 		$43.7M Buy
657,819
+126,891
+24% +$8.2M 1.34% 17
2025
Q3 		$35.7M Sell
530,928
-10,948
-2% -$866K 1.08% 20
2025
Q2 		$47.3M Sell
541,876
-26,586
-5% -$2.08M 1.43% 14
2025
Q1 		$38.8M Sell
568,462
-20,286
-3% -$1.66M 1.29% 16
2024
Q4 		$45.8M Sell
588,748
-29,135
-5% -$2.16M 1.36% 15
2024
Q3 		$41.4M Sell
617,883
-70,619
-10% -$5.8M 1.25% 19
2024
Q2 		$78.1M Buy
688,502
+14,031
+2% +$1.77M 2.28% 5
2024
Q1 		$93.5M Sell
674,471
-11,336
-2% -$1.42M 2.68% 3
2023
Q4 		$85.1M Buy
685,807
+41,014
+6% +$4.19M 2.56% 3
2023
Q3 		$60.2M Buy
644,793
+66,703
+12% +$7.52M 1.8% 5
2023
Q2 		$74.3M Sell
578,090
-6,376
-1% -$771K 2.02% 3
2023
Q1 		$67.9M Buy
584,466
+6,967
+1% +$780K 1.96% 3
2022
Q4 		$65.4M Buy
577,499
+8,817
+2% +$968K 2.05% 2
2022
Q3 		$45.8M Sell
568,682
-7,829
-1% -$663K 1.48% 4
2022
Q2 		$43M Sell
576,511
-31,789
-5% -$2.9M 1.3% 6
2022
Q1 		$77.8M Sell
608,300
-54,416
-8% -$5.95M 1.84% 4
2021
Q4 		$89M Buy
662,716
+56,388
+9% +$8.1M 1.78% 6
2021
Q3 		$82.9M Sell
606,328
-4,232
-0.7% -$534K 1.72% 5
2021
Q2 		$65.2M Buy
610,560
+27,732
+5% +$2.66M 1.17% 11
2021
Q1 		$52.4M Buy
582,828
+146,928
+34% +$13.8M 0.97% 11
2020
Q4 		$40.3M Buy
435,900
+55,180
+14% +$4.93M 0.77% 19
2020
Q3 		$39.2M Buy
380,720
+2,304
+0.6% +$241K 1.04% 12
2020
Q2 		$38.4M Sell
378,416
-35,044
-8% -$3.13M 1.09% 12
2020
Q1 		$27.8M Buy
413,460
+48,856
+13% +$3.04M 1% 15
2019
Q4 		$19.9M Sell
364,604
-799,200
-69% -$37.9M 0.51% 73
2019
Q3 		$43.4M Buy
1,163,804
+340,984
+41% +$13.2M 1.18% 2
2019
Q2 		$30.8M Sell
822,820
-97,228
-11% -$3.06M 0.76% 25
2019
Q1 		$27.4M Sell
920,048
-42,896
-4% -$1.51M 0.69% 31
2018
Q4 		$28.8M Buy
962,944
+78,884
+9% +$2.5M 0.81% 16
2018
Q3 		$31.6M Sell
884,060
-286,960
-25% -$8.9M 0.75% 27
2018
Q2 		$27.8M Buy
1,171,020
+58,544
+5% +$1.24M 0.69% 43
2018
Q1 		$20.6M Sell
1,112,476
-38,444
-3% -$568K 0.5% 70
2017
Q4 		$16.5M Sell
1,150,920
-430,900
-27% -$5.6M 0.39% 108
2017
Q3 		$19.3M Buy
1,581,820
+311,472
+25% +$5.51M 0.46% 80
2017
Q2 		$23.2M Buy
1,270,348
+222,456
+21% +$4.11M 0.58% 54
2017
Q1 		$22.3M Sell
1,047,892
-155,568
-13% -$3.04M 0.57% 58
2016
Q4 		$18M Buy
1,203,460
+308,432
+34% +$5.46M 0.47% 70
2016
Q3 		$19.6M Buy
+895,028
New +$19.9M 0.51% 70

Other funds holding DXCM

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Peregrine Capital Management's DXCM Position: Q2 2026 in Review

Peregrine Capital Management increased its DexCom (DXCM) stake by 7.8% in Q2 2026, buying an estimated $3.2M and bringing the position to 664,581 shares worth $44.8M. The position accounts for 1.45% of the portfolio, ranked #11.

Peregrine Capital Management first reported a position in DXCM in Q3 2016 and has held it in 40 quarters since. The position peaked at $93.5M in Q1 2024. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Peregrine Capital Management held 664,581 shares of DexCom worth $44.8M as of Q2 2026.
  • Peregrine Capital Management bought 48,041 DexCom shares in Q2 2026, an estimated $3.2M.
  • DexCom made up 1.45% of Peregrine Capital Management's portfolio in Q2 2026, its #11 holding.
  • Peregrine Capital Management first reported a position in DexCom in Q3 2016 and has held it in 40 quarters since.
  • Peregrine Capital Management's DexCom position peaked at $93.5M in Q1 2024.
  • 224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.